Axogen Inc vs Bank of Montreal — how do they compare? Axogen Inc trades at $38.5 (market cap $2.06B), while Bank of Montreal trades at $180.98 (market cap $125.53B). The key difference: Bank of Montreal is far larger — about 60.9× Axogen Inc's market cap, and Bank of Montreal pays a 2.74% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.
| AXGN | BMO | |
|---|---|---|
Market Cap | $2.06B | $125.53B |
Sector | Technology | Financials |
52-Week High | $46.19 | $180.86 |
52-Week Low | $11.28 | $110.44 |
Enterprise Value | $1.98B | — |
Dividend Yield | — | 2.74% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
BMO trades at $178.69, down 0.15% today, with a bullish technical signal supported by moving averages and key resistance at $180. The company reported strong Q1 2026 earnings of $2.68 per share, beating estimates, and maintains a solid net income margin of 25.92%. Recent acquisitions and dividend increases highlight strategic growth, while analyst sentiment is balanced with 44% buy ratings.
Outlook remains positive driven by consistent earnings beats and expansion in metals & mining banking. Risks include valuation above historical norms with a P/E of 19.48 and exposure to interest rate sensitivity. The stock offers a compelling dividend yield but faces macroeconomic headwinds that could pressure future performance.
Trailing returns across standard periods
Latest headlines on both assets
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →Bank of Montreal is a diversified financial-services provider based in North America, operating four business segments: Canadian personal and commercial banking, U.S. P&C banking, wealth management, and capital markets. The bank's operations are primarily in Canada, with a material portion also in the U.S.
Read more on BMO →